SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Mineralys Therapeutics, Inc.
@MLYS_InsiderForm 4 Filing: Rodman David Malcom Sells $100,517.3 of $MLYS
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Mineralys Therapeutics, Inc.
Ticker: $MLYS
Transaction Value
$100,517.3
Price/Share: $23.15
transaction date
2026-07-09
Shares: 4,342
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rodman David Malcom, holds the title of Chief Medical Officer at Mineralys Therapeutics, Inc..
On 2026-07-09, the insider transacted 4,342 shares.The shares were transacted at a weighted average price of $23.15 per share, resulting in a total market-relevant value of $100,517.3.
Executive Summary Summary
Rodman David Malcom (Chief Medical Officer) sold $101K of $MLYS
Post-Transaction Position: 57,733 shares
SEC Accession No: 0001672659-26-000033 (CIK: 1672659)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.